ANNX - Rega marang bathi mangsa ngarep annexonbio.com
Therapeutic platform developer Annexon, Inc. (ANNX) is systematically deploying capital toward costly clinical trials, financing them through fresh equity offerings. This price chart reflects a current P/E ratio of 0.00. Annexon, Inc. (ANNX) is developing treatments for severe brain pathologies, implementing energy-efficient solutions and strictly adhering to environmental disposal regulations. The business relies on innovations in the field of neuromedicine.
Ringkesan rincian data analitis Annexon Biosciences Inc. (ANNX)
- nilai saham lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- data ekuitas miturut neraca:
- rincian struktur utang lan likuiditas bisnis:
Utang marang Ekuitas Annexon, Inc.|ANNX - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Annexon, Inc.|ANNX - Utang agregat perusahaan|Utang marang nilai buku Annexon, Inc.|ANNX - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Annexon|Likuiditas cepet annexonbio.com
- statistik bathi lan rasio pasar:
ANNX - Bathi perusahaan|Proyeksi bathi mangsa ngarep Annexon, Inc.|ANNX - Koefisien rega marang bathi|Prakiraan rega marang bathi Annexon Inc.|ANNX - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Annexon, Inc.|ANNX - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Annexon|ANNX - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan annexonbio.com|ANNX - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Annexon, Inc.
- data dodolan lan asil:
Ringkesan analitik perusahaan:Annexon ANNX
Annexon, Inc. (ANNX) is protected by a patent barrier in the development of complement inhibitors for the therapy of neurological pathologies. The company's forward P/E ratio reflects current market value relative to expected future earnings. Investors use this coefficient to assess the risk of overpaying for potential business growth. This price action reflects the extent to which the market prices in the issuer's technological superiority. Analysis based on the company's forward P/E ratio helps determine the balance point between yield and asset overheating.
Pesaing langsung
Rega marang bathi mangsa ngarep Biogen (BIIB)|Neurocrine - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Regencell RGC|AXSM: Rasio rega marang bathi mangsa ngarep|ACADIA Pharmaceuticals - Pangali Forward P/E|Rasio prakiraan rega marang bathi xenon-pharma.com|VKTX (Viking Therapeutics, Inc.) - Prakiraan rega marang bathi|Rasio rega marang bathi mangsa ngarep SUPN|Rega marang bathi mangsa ngarep Catalyst Pharmaceuticals Inc|Rasio prakiraan rega marang bathi Denali Corp DNLI|Rega marang bathi mangsa ngarep Harmony Biosciences (HRMY)|biohavenpharma.com - Rasio rega marang bathi mangsa ngarep|Amylyx Pharmaceuticals, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TRVI|Praxis Medicines - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Anavex Life Sciences Corp AVXL|CeriBell, Inc. (CBLL) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep PRTA|ALEC (Alector Inc.) - Pangali Forward P/E|Prakiraan rega marang bathi Omeros Corp. (OMER)|Prakiraan rega marang bathi NGNE (Neurogene Corp)|Kapitalisasi marang proyeksi bathi AC Immune Inc|Pangali Forward P/E VYGR (Voyager Therapeutics)|Pangali Forward P/E neumoratx.com NMRA|SCLX - Rega marang bathi mangsa ngarep|TVGN (Tevogen Bio Holdings Inc.) - Rasio rega marang bathi mangsa ngarep|alphacognition.com (ACOG) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep CGTX|Prakiraan rega marang bathi IKT|Rasio rega marang bathi mangsa ngarep SAVA (cassavasciences.com)|Rega marang bathi mangsa ngarep Assertio Holdings, Inc. (ASRT)|coyatherapeutics.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E VTGN (Vistagen)|Ovid Therapeutics Inc (OVID) - Rasio prakiraan rega marang bathi|ABOS: Prakiraan rega marang bathi|CRVO - Pangali Forward P/E|alteritytherapeutics.com (ATHE) - Rega marang bathi mangsa ngarep|Clene - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep PepGen Inc|Rasio prakiraan rega marang bathi Jupiter Neurosciences, Inc. JUNS|Pangali Forward P/E RLMD|Pangali Forward P/E annovisbio.com (ANVS)|Rega marang bathi mangsa ngarep Grace Therapeutics GRCE|AIFF: Rasio rega marang bathi mangsa ngarep|KLTO - Rega marang bathi mangsa ngarep|NRSN (NeuroSense Therapeutics) - Rasio rega marang bathi mangsa ngarep|RVPH: Pangali Forward P/E|Rasio prakiraan rega marang bathi MetaVia (MTVA)|Prakiraan rega marang bathi NRXS|Rasio rega marang bathi mangsa ngarep HSDT (Helius Medical Technologies Inc.)|Rega marang bathi mangsa ngarep Passage Bio, Inc. (PASG)|NEUP - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Minerva Neurosciences NERV|ATHA: Rasio rega marang bathi mangsa ngarep|ADXN: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ALZN (Alzamend Neuro, Inc.)|CYCN: Pangali Forward P/E|PTIX - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Pasithea Therapeutics Corp|Rasio rega marang bathi mangsa ngarep CRGT (Cortigent Medical)|Pangali Forward P/E ATXI|Prakiraan rega marang bathi Brainstorm Cell Therapeutics Inc. BCLI|Cara Therapeutics, Inc - Prakiraan rega marang bathi|Kapitalisasi marang proyeksi bathi Chromocell (CHRO)|Eliem - Pangali Forward P/E|ITCI - Pangali Forward P/E|Longboard Pharmaceuticals, Inc. (LBPH) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep MRNS|Rega marang bathi mangsa ngarep NKGen|Rasio rega marang bathi mangsa ngarep NRBO (NeuroBo Pharma)|Prakiraan rega marang bathi SAGE (Sage Therapeutics, Inc.)|synaptogen.com - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Trevena TRVN|VIGL: Rasio rega marang bathi mangsa ngarep|Anew Medical - Pangali Forward P/E|Rasio prakiraan rega marang bathi Cerevel Corp
